Cleared Traditional

K173620 - Mag Vita TMS Therapy System w/Theta Burst Stimulation (FDA 510(k) Clearance)

Aug 2018
Decision
265d
Days
Class 2
Risk

K173620 is an FDA 510(k) clearance for the Mag Vita TMS Therapy System w/Theta Burst Stimulation. This device is classified as a Transcranial Magnetic Stimulator (Class II - Special Controls, product code OBP).

Submitted by Tonica Elektronik A/S (Farum, DK). The FDA issued a Cleared decision on August 14, 2018, 265 days after receiving the submission on November 22, 2017.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5805. A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder..

Submission Details

510(k) Number K173620 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2017
Decision Date August 14, 2018
Days to Decision 265 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OBP - Transcranial Magnetic Stimulator
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.5805
Definition A Transcranial Magnetic Stimulator Is A Device That Delivers Brief Duration, Rapidly Alternating, Or Pulsed, Magnetic Fields To Induce Electrical Currents That Are Directed At Spatially Discrete Regions Of The Cerebral Cortex For The Treatment Of Major Depressive Disorder.